JIANGSU KANION PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.8 CNY | +2.48% |
|
+4.65% | -3.51% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jiangsu Kanion Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The Company's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The Company distributes its products mainly within domestic markets.
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
19.8
CNY
Average target price
25.17
CNY
Spread / Average Target
+27.14%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.51% | 1.6B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 600557 Stock
- News Jiangsu Kanion Pharmaceutical Co.,Ltd.
- Kanion Pharmaceutical's Jinzhen Oral Liquid Shows Positive Result in Clinical Trial
